首頁 > 市場調查報告書 > 製藥

處方藥

市場調查報告書

商品編碼

2008154

Suboxone市場：按類型、劑型、分銷管道和地區分類。

Suboxone Market, By Type, By Formulation, By Distribution Channel, By Geography

出版日期: 2026年03月12日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，丁丙諾啡市場規模估計為74億美元，預計2033年將達到96億美元。預計2026年至2033年，其複合年成長率將達4.1%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	74億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	4.10%	預計金額（2033 年）	96億美元

Suboxone是一種處方藥，用於抑制鴉片類藥物（如鎮痛藥）的作用，從而防止鴉片類藥物成癮。 Suboxone可單獨使用，也可與其他藥物合併使用治療鴉片類藥物成癮。 Suboxone屬於鴉片類拮抗劑、止痛藥和鴉片類部分致效劑類藥物。 Suboxone由Buprenornhine和納洛酮組成。Buprenornhine是一種鴉片類藥物，有時也被稱為麻醉劑。納洛酮的作用機轉是拮抗鴉片類藥物的作用，例如鎮痛和欣快感，從而預防可能產生的鴉片類藥物依賴。

市場動態

預計在預測期內，新上市的丁丙諾啡產品數量的不斷增加將推動全球丁丙諾啡市場的成長。 2018年9月，全球製藥公司蘭尼特公司（Lannett Co Inc.）推出了五款產品，包括Buprenornhine+納洛酮舌下片。

此外，預計特定地區鴉片類藥物處方量的增加將在預測期內推動市場成長。例如，2021年11月發表在新的開放取用臨床日誌《臨床醫學》（ClinicalMedicine）上的一項研究發現，儘管全球處方率呈下降趨勢，但英國人均處方鴉片類藥物用於疼痛管理的消費量仍居世界首位。

此外，慢性疼痛盛行率的不斷上升預計將在預測期內推動全球丁丙諾啡市場的成長。例如，美國疾病管制與預防中心（CDC）於2018年9月發布的數據顯示，2016年美國約有20.4%（5000萬人）的成年人患有慢性疼痛，其中8.0%（1960萬人）的慢性疼痛嚴重影響了他們的生活，且患病率老齡化成長而增加。

本報告的主要特點

本報告對全球丁丙諾啡市場進行了詳細分析，包括預測期（2026-2033 年）的市場規模和複合年成長率，以 2025 年為基準年。
此外，它還確定了每個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本文根據以下參數，介紹了全球丁丙諾啡市場主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球Suboxon市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球亞硫酸氫鉀市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Indivior PLC.
Dr. Reddy's Laboratories Ltd.
Amneal Pharmaceuticals LLC.
Mylan NV
Novartis AG
Teva Pharmaceutical Industries Ltd.
Mallinckrodt
Lannett Co Inc.
Rhodes Pharmaceuticals LP
Alvogen
Sun Pharmaceutical Industries Ltd.
Alkem Labs
Hikma Pharmaceuticals PLC

第9章

分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI5000

Suboxone Market is estimated to be valued at USD 7.4 Bn in 2026 and is expected to reach USD 9.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 7.4 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.10%	2033 Value Projection:	USD 9.6 Bn

Suboxone is a prescription opioid medication that is used to inhibit the effects of opioid medications, such as pain relief, which can lead to opioid dependence. Suboxone can be used alone or in combination with other drugs to treat opioid addiction. Suboxone belongs to a drug class known as opioid antagonists, analgesics, and opioid partial agonists. Suboxone is composed of buprenorphine and naloxone. Buprenorphine is an opioid medicine, sometimes known as a narcotic. Naloxone counteracts the benefits of opioid medications, such as pain relief and feelings of well-being, which can lead to opioid dependence.

Market Dynamics

The increasing product launches for suboxone is expected to drive the growth of global suboxone market over the forecast period. In September 2018, Lannett Co Inc., a global manufacturer of pharmaceutical products, launched five products that include Buprenorphine plus Naloxone Sublingual tablets, and others.

Moreover, increasing prescription of opioids in certain regions is expected to drive the market growth over the forecast period. For instance, a research published by EclinicalMedicine, a new open access clinical journal, in November 2021 stated that the U.K. had the highest consumption rate of prescription opioids for pain management per capita in the world, despite declining rates globally.

Furthermore, increasing prevalence of chronic pain is expected to drive the growth of global suboxone market over the forecast period. For instance, according to data published by Centers for Disease Control and Prevention in September 2018, stated that an estimated 20.4% of the U.S. adults (50.0 million) had chronic pain and 8.0% of the U.S. adults (19.6 million) had high-impact chronic pain with higher prevalence associated with advancing age in 2016.

Key features of the study

This report provides an in-depth analysis of the global suboxone market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global suboxone market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Indivior PLC, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC., Mylan N.V., Novartis AG, Teva Pharmaceutical Industries Ltd., Mallinckrodt, Lannett Co Inc., Rhodes Pharmaceuticals L.P., Alvogen, Sun Pharmaceutical Industries Ltd., Alkem Labs, and Hikma Pharmaceuticals PLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global suboxone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global suboxone market

Market Segmentation

By Type
- Branded
- Generics
By Formulation
- Tablets
- Films
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Indivior PLC
- Reddy's Laboratories Ltd.
- Amneal Pharmaceuticals LLC.
- Mylan N.V.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Mallinckrodt
- Lannett Co Inc.
- Rhodes Pharmaceuticals L.P.
- Alvogen
- Sun Pharmaceutical Industries Ltd.
- Alkem Labs
- Hikma Pharmaceuticals PLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Formulation
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
New Product Launches
Regulatory Scenario
PEST Analysis
PORTER's Analysis
Key Developments
Brand Analysis
Strategic Agreement, Merger And Acquisitions

4. Global Suboxone Market, By Type, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Branded
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Generics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Suboxone Market, By Formulation, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Tablets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Films
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Suboxone Market, By Distribution Channel, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Hospital pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Suboxone Market, By Region, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - UK
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Indivior PLC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Dr. Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amneal Pharmaceuticals LLC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mallinckrodt
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lannett Co Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Rhodes Pharmaceuticals L.P.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Alvogen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Alkem Labs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies